Author Archive: dslevine

LONDON and BOSTON, May 08, 2024 (GLOBE NEWSWIRE) — Treos Bio, a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision peptide immunotherapies, said investigators will present new results from a phase 2 trial of the company’s lead product candidate PolyPEPI1018 in combination with Roche’s PD-L1 inhibitor atezolizumab in patients with […]

Levine Media Group has launched Feeding Time, a monthly newsletter available on LinkedIn that provides a monthly round-up of episodes from The Bio Report, RARECast, and Life Sciences D’n’A podocasts to nourish the mind. More 

SAN JOSE, Calif., April 30, 2024 (GLOBE NEWSWIRE) — Matt Gardner, Board President of the California Biomanufacturing Center and Chair of the BioProcess to Product Network (BioP2P), is scheduled to speak at the 2024 SynBioBeta Global Biology Conference. Gardner’s Lightning Talk titled “Seeing Alternative Investors as Growth Partners” will take place at 11 a.m. on […]

SAN FRANCISCO, April 23, 2024 (GLOBE NEWSWIRE) — The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) has granted Amfora, Inc. an exemption for its gene-edited, ultra-high protein soybeans. More

WILMINGTON, Del., March 11, 2024 (GLOBE NEWSWIRE) — The U.S. Patent and Trademark Office has issued a patent, US11920140, for the use of CRISPR technologies to edit organellar genomes to NAPIGEN, Inc., a biotechnology company that specializes in mitochondrial and chloroplast genome engineering. Read the full release.

Levine Media Groups has launched the Life Sciences D’n’A podcast, a video podcast that explores data analytics and AI in the life sciences. It  is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and […]

VACAVILLE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — The California Biomanufacturing Center said the City of Vacaville awarded it a two-year, $750,000 grant through funding provided under the American Rescue Plan Act of 2021 to retrain displaced workers and provide skilled training for new workers. Read the full release here.

Levine Media Group’s Daniel Levine will moderate a series of master classes on therapeutic modalities during the Global Genes’ 2023 RARE Advocacy Summit at the Sheraton San Deigo Hoel & Marina. The master class will cover small molecules and biologics, RNA therapies, gene therapy and gene editing, and a case study of therapies for spinal […]

You can find older news here.